Smarter. Stronger. Together. Progressing Towar... - CLL Support

CLL Support

22,990 members39,474 posts

Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

lankisterguy profile image
lankisterguyVolunteer
0 Replies

clinicaloptions.com/oncolog...?

-

This is an educational series intended for medical professionals, but patients that understand MedSpeak should be able to learn from it. It is sponsored by several organizations including the CLL Society.

-

In this CME/CE-certified activity, review the latest multidisciplinary strategies for optimizing care of patients with CLL, including discussion of effective patient education on treatment selection and toxicity management.

Discussion topics include:

• Evolving CLL Treatment Recommendations

• Individualizing Frontline Therapy for Patients With Chronic Lymphocytic Leukemia: Putting Evidence Into Practice

• Addressing Patient Knowledge Gaps, Concerns, and Misperceptions About CLL

• Assessing Measurable Residual Disease in Chronic Lymphocytic Leukemia

• Multidisciplinary Perspectives on Managing Adverse Events With BCL-2 and PI3K Inhibitors in CLL

• Multidisciplinary Perspectives on CLL-Related Symptoms and Managing Adverse Events With BTK Inhibitors

-

Len

Written by
lankisterguy profile image
lankisterguy
Volunteer
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD

In this Patient Power video - Dr. Brown is very clear about the advantages of Zanubrutinib over...

Advances in Targeted Therapy for R/R CLL OncLive videos & transcripts by Nirav Shah MD & Nicole Lamanna MD

Advances in Targeted Therapy for R/R CLL (These OncLive presentations are intended for medical...

BTK inhibitors for the treatment of CLL - the current state of play of 'brutinibs'

In just a short time, in many places, BTK inhibitors (BTKi) have largely replaced...

YABTKi or Yet Another BTK inhibitor - the A to Z list of Bruton's Tyrosine Kinase Inhibitors for CLL following Ibrutinib's success

I'll admit that YABTKi is not a recognised CLL related acronym, (acronym lists are here...

New compendium of quality CLL resources for patients + your hematologist

I am sharing a collection of high quality CLL resources for both patients and hematologists....